293
Views
9
CrossRef citations to date
0
Altmetric
Original

Medication management of pediatric eating disorders

, MD FRCPC, &
Pages 183-188 | Published online: 11 Jul 2009

References

  • Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, et al. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. American Journal of Psychiatry 1992; 149: 82–87
  • American Psychiatric Association. Diagnostic criteria from DSM-IV. The American Psychiatric Association, Washington DC 1994
  • American Psychiatric Association. Treatment of patients with eating disorders, third edition. American Journal of Psychiatry 2006; 163(suppl)4–54
  • Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Archives of General Psychiatry 2003; 60: 1109–1116
  • Attia E, Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa?. American Journal of Psychiatry 1998; 155: 548–551
  • Attia E, Mayer L, Killory E. Medication response in the treatment of patients with anorexia nervosa. Journal of Psychiatric Practice 2001; 7: 157–162
  • Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, et al. Amitriptyline in the treatment of anorexia nervosa: A double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology 1985; 5: 10–16
  • Boachie A, Goldfield GS, Spettigue W. Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: Case reports. International Journal of Eating Disorders 2003; 33: 98–103
  • Brownley KA, Berkman ND, Sedway JA, Lohr KN, Bulik CM. Binge eating disorder treatment: A systematic review of randomized controlled trials. International Journal of Eating Disorders 2007; 40: 337–348
  • Bryant-Waugh RJ, Cooper PJ, Taylor CL, Lask BD. The use of the eating disorder examination with children: A pilot study. International Journal of Eating Disorders 1996; 19: 391–397
  • Bulik CM, Berkman ND, Brownley KA, Sedway JA, Lohr KN. Anorexia nervosa treatment: A systematic review of randomized controlled trials. International Journal of Eating Disorders 2007; 40: 310–320
  • Dennis K, le Grange D, Bremer J. Olanzapine use in adolescent anorexia nervosa. Eating and Weight Disorders 2006; 11: e53–e56
  • Devlin MJ, Goldfein JA, Petkova E, Liu L, Walsh BT. Cognitive behavioral therapy and fluoxetine for binge eating disorder: Two-year follow-up. Obesity (Silver Spring) 2007; 15: 1702–1709
  • Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB. Valproic acid hepatic fatalities: A retrospective review. Neurology 1987; 37: 379–385
  • Fairburn CG. Evidence-based treatment of anorexia nervosa. International Journal of Eating Disorders 2005; 37(Suppl.)S26–S30
  • Fairburn CG, Cooper Z. The Eating Disorder Examination. Binge eating, nature, assessment and treatment, CG Fairburn, GT Wilson. Guilford Press, New York 1993; 317–360
  • Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Archives of General Psychiatry 1992; 49: 139–147
  • Frank GK, Bailer UF, Henry S, Wagner A, Kaye WH. Neuroimaging studies in eating disorders. CNS Spectrums 2004; 9: 539–548
  • Gowers S, Bryant-Waugh R. Management of child and adolescent eating disorders: The current evidence base and future directions. Journal of Child Psychology and Psychiatry 2004; 45: 63–83
  • Grilo CM, Masheb RM, Wilson GT. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: A randomized double-blind placebo-controlled comparison. Biological Psychiatry 2005; 57: 301–309
  • Hudson JI, Hiripi E, Pope Jr HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry 2007; 61: 348–358
  • Kafantaris V, Leigh E, Berest A, Hertz S. Pilot study of olanzapine in the treatment of anorexia nervosa. American Academy of Child and Adolescent Psychiatry 54th Annual Meeting Poster Presentation, Boston, MA 26 October 2007, 2007
  • Kaye W, Gendall K, Strober M. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biological Psychiatry 1998; 44: 825–838
  • Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C, et al. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biological Psychiatry 2001; 49: 644–652
  • Kotler LA, Devlin MJ, Davies M, Walsh BT. An open trial of fluoxetine for adolescents with bulimia nervosa. Journal of Child and Adolescent Psychopharmacology 2003; 13: 329–335
  • Kotler LA, Walsh BT. Eating disorders in children and adolescents: Pharmacological therapies. European Child and Adolescent Psychiatry 2000; 9(Suppl.1)I108–I116
  • McElroy SL, Guerdjikova A, Kotwal R, Welge JA, Nelson EB, Lake KA, et al. Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. Journal of Clinical Psychiatry 2007a; 68: 390–398
  • McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR. Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study. Biological Psychiatry 2007b; 61: 1039–1048
  • Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australasian Psychiatry 2005; 13: 72–75
  • Ramoz N, Versini A, Gorwood P. Eating disorders: An overview of treatment responses and the potential impact of vulnerability genes and endophenotypes. Expert Opinion on Pharmacotherapy 2007; 8: 2029–2044
  • Ricca V, Mannucci E, Mezzani B, Di BM, Zucchi T, Paionni A, et al. Psychopathological and clinical features of outpatients with an eating disorder not otherwise specified. Eating and Weight Disorders 2001; 6: 157–165
  • Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine. Journal of the American Academy of Child Adolescent Psychiatry 1993; 32: 792–797
  • Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM. Bulimia nervosa treatment: A systematic review of randomized controlled trials. International Journal of Eating Disorders 2007
  • Tanofsky-Kraff M, Yanovski SZ, Yanovski JA. Comparison of child interview and parent reports of children's eating disordered behaviors. Eating Behaviours 2005; 6: 95–99
  • Treasure JL. Getting beneath the phenotype of anorexia nervosa: The search for viable endophenotypes and genotypes. Canadian Journal of Psychiatry 2007; 52: 212–219
  • Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. British Journal of Psychiatry 1984; 144: 288–292
  • Walsh BT, Kaplan AS, Attia E, Olmsted M, Parides M, Carter JC, et al. Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. Journal of the American Medical Association 2006; 295: 2605–2612
  • Wilson GT, Shafran R. Eating disorders guidelines from NICE. Lancet 2005; 365: 79–81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.